Tissue proteases convert CCL23 into potent monocyte chemoattractants in patients with chronic rhinosinusitis - 06/04/16
Doi : 10.1016/j.jaci.2015.09.029
Julie A. Poposki, MS a, Anjeni Keswani, MD a, Julie K. Kim, MD a, Aiko I. Klingler, PhD a, Lydia A. Suh, BS a, James Norton, MS a, Roderick G. Carter, BS a, Anju T. Peters, MD a, Kathryn E. Hulse, PhD a, Leslie C. Grammer, MD a, Bruce K. Tan, MD b, David B. Conley, MD b, Juan C. Jaen, PhD c, Thomas J. Schall, PhD c, Robert C. Kern, MD a, b, Atsushi Kato, PhD a, b 
a Division of Allergy-Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill
b Department of Otolaryngology, Northwestern University Feinberg School of Medicine, Chicago, Ill
c ChemoCentryx, Mountain View, Calif
| Supported in part by National Institutes of Health grants R21 HL113913, R01 AI104733, U19 AI106683, and R37 HL068546 and by a grant from the Ernest S. Bazley Foundation. |
|
| Disclosure of potential conflict of interest: K. E. Hulse has received a grant from the National Institutes of Health (NIH; BIRCWH/K12 award). L. C. Grammer has received grants and travel support from the NIH; has received grants from the Bazley Foundation, the NIH, the Food Allergy Network, and S&C Electric; has consultant arrangements with Astellas Pharmaceuticals; is employed by Northwestern University and the Northwestern Medical Faculty Foundation; has received payment for lectures from the American Academy of Allergy, Asthma & Immunology and Mount Sinai; and has received royalties from Lippincott, UpToDate, BMJ, and Elsevier. B. K. Tan has received grants from the NIH (K23 DC012067, U19 AI106683). T. J. Schall is employed by, has patent applications through, and has stock/stock options in ChemoCentryx. A. Kato has received research support from the NIH (R21 HL113913 and R01 AI104733) and the Janssen Research Fund. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2015
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 137 - N° 4
P. 1274 - avril 2016 Retour au numéro
Article précédent
- Staphylococcus aureus density on lesional and nonlesional skin is strongly associated with disease severity in atopic dermatitis
- Marie Tauber, Stefana Balica, Chiung-Yueh Hsu, Catherine Jean-Decoster, Christophe Lauze, Daniel Redoules, Cécile Viodé, Anne-Marie Schmitt, Guy Serre, Michel Simon, Carle F. Paul
- Sensitization phenotypes based on protein groups and associations to allergic diseases in children
- Ann-Marie M. Schoos, Jacob D. Kattan, Gustavo Gimenez, Hugh A. Sampson
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?